Our Stocks to Watch tomorrow include Lexon Technologies Inc. (OTCBB: LEXO), BizAuctions Inc. (OTC: BZCN), Wellstar International Inc. (OTCBB: WLSI), Solos Endoscopy Inc. (OTC: SNDY), Sino Gas International Holdings Inc. (OTCBB: SGAS) and Paradigm Medical Industries Inc. (OTCBB: PDMI).
LEXON TECHNOLOGIES INCORPORATED (OTCBB: LEXO)
"Up 320.00% on Wednesday"
Detailed Quote: http://www.otcpicks.com/quotes/LEXO.php
Lexon Technologies (formerly Paragon Toner Inc.) is an environmental manufacturer of recycled toner for laser printers, fax and multifunction copiers. The Company primarily services large retailers and distributors but also has a growing internet division. Paragon has over 350 product lines with product prices generally 30-60% less than original (OEM) toner cartridges. With a product defect percentage of less than 1%, Paragon also offers a 100% guarantee on all of its products. The company, based in
LEXO News:
October 14 - Lexon Technologies, Inc. Completes Reverse Merger with Paragon Toner
Lexon Technologies, Inc. (OTCBB: LEXO) has completed a reverse merger with Paragon Toner Inc. (www.ptoner.com), a Southern
Under the terms of the Merger Agreement, Lexon Technologies has issued 347,448,444 shares to the shareholders of Paragon in return of 100% ownership of Paragon. The company will retain the name of Lexon Technologies, Inc. and the symbol LEXO.OB.
Since its inception in 1993, Paragon has seen consistent growth and profitability. For the year 2008, Paragon recycled and sold over 200,000 toner cartridges. Currently, the recycled toner market has grown into a 12 billion dollar business and Paragon has seen an unprecedented increase of both sales and profits during the last three years. Paragon supplies primarily large retailers and distributors of the product as well as operating an online retail division.
James Park, new CEO of Lexon and the former owner of Paragon, said that, "In the past we have amply provided for our families and our employees by emphasizing profits, and growth, however, from this point forward we seek to do the same for our shareholders and investors."
Mr. Park further added, "We believe our timing is impeccable. With the worldwide awareness of green sustainable or recycled goods, and the need for cheaper products, timed with a rebound in the markets, we hope to capitalize with continued growth and solid financials."
BIZAUCTIONS INCORPORATED (OTC: BZCN)
"Up 166.67% on Wednesday"
Detailed Quote: http://www.otcpicks.com/quotes/BZCN.php
BizAuctions, Inc. is a prime provider of commercial eBay liquidation services for excess inventory, overstock items, and returns. Our clients have included some of the Nation's leading retail names at the forefront of their industries. BizAuctions addresses the $60 billion excess inventory problem for clients by sending trucks to pick up pallets of excess inventory, selling the inventory on eBay, and collecting payment. We provide our clients with a new sales channel to generate additional revenue on excess inventory, while at the same time freeing up their valuable storage and retail space. With a long-term strategy to provide eBay liquidation services to Fortune 1000 enterprises, BizAuctions is a clear and lucrative solution for most any business to liquidate its excess inventory on eBay.
BZCN News:
August 12 - AmeriResource Plans to Create Overstock.com-like Retail Web Site to Boost BizAuctions Revenue
AmeriResource Technologies, Inc. (OTC: ARIO) announced it is in the preliminary stages of creating a web site designed to sell certain discounted goods through a web platform that is intended to resemble an Overstock.com like web site.
Delmar Janovec, AmeriResource, CEO, noted, "BizAuctions (OTC: BZCN) primarily sells its products through its eBay platform and clothing articles through its newly opened retail store, Lucky 7's, in Southern California. Selling certain products directly to the public on a new web site may be a way to boost revenues and improve margins. We already have the staff and warehouse space to accommodate selling directly to the public so the only real additional cost will be the creation of the web site."
Mr. Janovec continued, "We understand that in order to significantly boost revenues it is very important that BizAuctions begins brand building by initiating a significant marketing campaign through traditional channels such a billboards, TV, pay per click ads, obtaining celebrity endorsements and the like. Over the coming months, AmeriResource and its subsidiaries are going to explore its options in launching a national marketing effort. It is clear from such penny stock companies like SpongeTech traded on the OTCBB that traditional marketing not only helps build your brand but also appears to have a positive impact on liquidity and share value."
"AmeriResource also is in the process of updating its own web site and subsidiary web sites as well as its ATTO Solutions web site which has dated information. We are committed to delivering up to date and accurate information to potential customers and investors alike. Management is working diligently to bring AmeriResource filings current with the SEC and revamping our web site to be in compliance with the current information requirements," concluded Janovec.
WELLSTAR INTERNATIONAL INCORPORATED (OTCBB: WLSI)
"Up 100.00% on Wednesday"
Detailed Quote: http://www.otcpicks.com/quotes/WLSI.php
Wellstar International, Inc., through its wholly owned operating subsidiary Trillenium Medical Imaging, Inc. (TMI), is poised to become a leading diagnostic company in the health care industry. TMI has developed and is marketing fully calibrated and functional, thermal imaging systems that utilize state-of-the-art infrared technologies and proprietary software to accurately and cost-effectively measure physiological changes in the human body. More information on the Company and its unique diagnostic software and product line is available on Wellstar's corporate Website.
WLSI News:
October 14 - Wellstar International Announces Funding
Wellstar International, Inc. (OTCBB: WLSI) has announced that it has entered into a financing agreement with JMJ Financial to provide the Company with an expected $1.2 million dollars in operational funding over the eighteen months. Details of the financing were contained in the Company's Form 8-K filing with the Securities and Exchange Commission on October 9, 2009.
The initial funding has been transferred to Wellstar and is expected to continue on a monthly basis. This funding will allow Wellstar to continue to operate in the near future and develop the completion of its Trillennium Medical Imaging System for rollout to the medical community. Although we have entered into a definitive agreements with respect to the financing with JMJ Financial, we cannot provide any guarantee that the funding outlined in the agreements will continue on a monthly basis or at all.
Wellstar International, Inc. seeks to be the first-to-market in deep tissue injury and pressure ulcer detection using its proprietary infrared imaging system. Thermal Imaging is a low cost, noncontact, non-radioactive diagnostic screening procedure designed for clinical evaluation. In addition, thermal imaging provides an ability to track the progress of therapies being utilized in a low cost, non-invasive manner. Thermal Imaging can detect signs of pressure ulcers before they are visible with the naked eye through detection of temperature changes at the site which allows for treatment of the pressure ulcer before it erupts. The TMI system can be used to scan all new patients into hospitals and long-term care facilities prior admittance and begin treating existing wounds before they are visible.
SOLOS ENDOSCOPY INCORPORATED (OTC: SNDY)
"Up 103.90% on Wednesday"
Detailed Quote: http://www.otcpicks.com/quotes/SNDY.php
Solos Endoscopy, Inc. is a healthcare technology company whose mission is to develop and market breakthrough technology, applications, medical devices and procedural techniques for the screening, diagnosis, treatment and management of medical conditions. Backed by technical support, Solos' sales team can help make the right buying decisions for the hospital, surgery center, or physician office.
SNDY News:
October 14 - Solos Endoscopy, Inc.'s FDA Approved MammoView™ Product Line to Obtain CE Mark
Company to Enter the $94 Billion European Medical Device Market
Solos Endoscopy, Inc. (OTC: SNDY) announced that the Company has taken the initial steps to obtain the CE Mark for its Food and Drug Administration (FDA) approved MammoView™ line of surgical endoscopy instruments. This will allow the MammoView™ line to be sold throughout the European Economic Union (EEU). The entire Solos Endoscopy product line has already received FDA approval for sale within the
Solos Endoscopy is working closely with its manufacturers to ensure all requirements of the Medical Devices Directive (MDD 93/42/EEC) are met. The Company is familiar with the steps that are to be taken to obtain the CE Mark for its MammoView™ line of surgical endoscopy instruments, as all of the Company's other medical devices have already obtained the CE Mark. Solos Endoscopy is currently in discussions with several companies, to act as its Authorized Representatives (EC REP) to liaison with its targeted European markets.
"Expanding into the EEU provides unlimited sales opportunities for Solos Endoscopy and our goal is to commence sales, within several European countries, in 2010," stated Bob Segersten, President of Solos Endoscopy, Inc.
SINO GAS INTERNATIONAL HOLDINGS (OTCBB: SGAS)
"Up 47.54% on Wednesday"
Detailed Quote: http://www.otcpicks.com/quotes/SGAS.php
The Company, through its indirectly wholly-owned subsidiary, Beijing Zhong Ran Wei Ye Gas Co., Ltd. ("Beijing Gas"), and the subsidiaries of Beijing Gas, is a leading developer of natural gas distribution systems in small and medium size cities in
SGAS News:
August 13 - Sino Gas International Holdings, Inc.'s 2nd Quarter of 2009 Earnings Conference Call
Sino Gas International Holdings, Inc. (OTCBB: SGAS) ("Sino Gas" or the "Company") announced that it will conduct a conference call at 8:00 a.m. Eastern Time on Wednesday, Aug 19, 2009 to discuss the second quarter of 2009 financial results.
Joining Mr. Yu-chuan Liu, President and Chief Executive Officer of Sino Gas, will be Mr. Yugang Zhang, Chief Financial Officer, and Ms. Chunying Chai, IR Officer.
Prior to the conference call, the Company plans to release its second quarter 2009 financial results on Wednesday, Aug 19, 2009.
To participate in the live conference call, please dial the following number: 800 688 0796 or 617 614.4070 for International callers, access Code 561 544 19.
If you are unable to participate in the call at this time, a 14-day replay will be available from 9:45 a.m. Aug 19, 2009. To access the replay, dial 888-286-8010 or 617-801-6888 for international callers, access Code 79770728.
PARADIGM MEDICAL INDUSTRIES INCORPORATED (OTCBB: PDMI)
"Up 57.14% on Wednesday"
Detailed Quote: http://www.otcpicks.com/quotes/PDMI.php
Paradigm Medical Industries, Inc. is a medical device company that develops, manufactures and distributes cutting edge, new innovative products in the diagnostic ultrasound and early glaucoma detection markets. Paradigm has the only patented technology utilizing photon laser for cataract removal. The Company is poised to capture a niche market within the Glaucoma and ultrasound microscopy fields. Paradigm Medical Industries markets its products to ophthalmologists, optometrists, universities, and clinics throughout the
PDMI News:
June 1 - Paradigm Medical Announces Plans to Release Its New Corneal Topographer, the Paravue, in the
Paradigm Medical Industries, Inc. (OTCBB: PDMI) announced that the Company will soon begin to introduce the first of its four new ophthalmic diagnostic devices, the Paravue, during the remainder of 2009. The Paravue is a sophisticated topographer utilizing Placido Disk Technology and an advanced software to provide accurate and detailed analysis of the anterior corneal surface.
Corneal topography — also known as videokeratography or corneal mapping — represents a significant advance in the measurement of the corneal curvature. Most corneal topographers evaluate 8,000 to 10,000 specific points across the entire corneal surface. By contrast, the Paravue processes more than 100,000 points. It also offers corneal wave front analysis with 2, 3 or 4 maps available for comparison.
The Paravue provides both a qualitative and quantitative evaluation of corneal curvature. It does so by utilizing a big placido disk with 24 concentric rings, which project onto the cornea to create a virtual image. The device compares this image to the target size, and the computer then calculates the corneal curvature. Advanced features including advanced rings editing, variable scales, refractive power map and more make the Paravue a valuable tool in the optometric and ophthalmic clinics.
"The addition of the Paravue to our existing ophthalmic product line fills an important segment that was missing," said Paradigm Medical President, Stephen Davis. "We are excited to offer not just another topographer, but one with many impressive features and incredibly friendly software that provides ease of use, flexible mapping and accuracy."
OTCPicks.com is located at
DO NOT BASE ANY INVESTMENT DECISION UPON ANY MATERIALS FOUND ON THIS REPORT. We are not registered as a securities broker-dealer or an investment adviser either with the U.S. Securities and Exchange Commission (the "SEC") or with any state securities regulatory authority. We are neither licensed nor qualified to provide investment advice. OTCPicks.com makes no recommendation that the purchase of securities of companies profiled in this web site is suitable or advisable for any person or that an investment such securities will be profitable. In general, given the nature of the companies profiled and the lack of an active trading market for their securities, investing in such securities is highly speculative and carries a high degree of risk. You are receiving this email because you have registered on OTCPicks.com or one of our affiliate companies.
The information contained in our report should be viewed as commercial advertisement and is not intended to be investment advice. The report is not provided to any particular individual with a view toward their individual circumstances. The information contained in our report is not an offer to buy or sell securities. We distribute opinions, comments and information free of charge exclusively to individuals who wish to receive them.
Our newsletter and website have been prepared for informational purposes only and are not intended to be used as a complete source of information on any particular company. An individual should never invest in the securities of any company profiled based solely on information contained in our reports. Individuals should assume that all information contained in the report about profiled companies is not trustworthy unless verified by their own independent research.
Any individual who chooses to invest in any securities should do so with caution. Investing in securities is speculative and carries a high degree of risk; you may lose some or all of the money that is invested. Always research your own investments and consult with a registered investment advisor or licensed stockbroker before investing.
Information contained in our report will contain "forward looking statements" as defined under Section 27A of the Securities Act of 1933 and Section 21B of the Securities Exchange Act of 1934. Subscribers are cautioned not to place undue reliance upon these forward-looking statements. These forward-looking statements are subject to a number of known and unknown risks and uncertainties outside of our control that could cause actual operations or results to differ materially from those anticipated. Factors that could affect performance include, but are not limited to, those factors that are discussed in each profiled company's most recent reports or registration statements filed with the SEC. You should consider these factors in evaluating the forward-looking statements included in the report and not place undue reliance upon such statements. We are committed to providing factual information on the companies that are profiled. However, we do not provide any assurance as to the accuracy or completeness of the information provided, including information regarding a profiled company's plans or ability to effect any planned or proposed actions. We have no first-hand knowledge of any profiled company's operations and therefore cannot comment on their capabilities, intent, resources, nor experience and we make no attempt to do so. Statistical information, dollar amounts, and market size data was provided by the subject company and related public information sources which we believe to be reliable but we cannot guarantee the accuracy of the information. To the fullest extent of the law, we will not be liable to any person or entity for the quality, accuracy, completeness, reliability, or timeliness of the information provided in the report, or for any direct, indirect, consequential, incidental, special or punitive damages that may arise out of the use of information we provide to any person or entity (including, but not limited to, lost profits, loss of opportunities, trading losses, and damages that may result from any inaccuracy or incompleteness of this information). We encourage you to invest carefully and read investment information available at the websites of the SEC at http://www.sec.gov and FINRA at http://www.finra.org.
Disclosure: OTCPicks.com has been compensated one million free trading shares by a non-controlling third party for PDMI advertising and promotional services.
